Categories
Pharmaceutical

Histopathology Testing Equipment Market to register a CAGR of 4.8% by the end of 2026

Global sales of histopathology testing equipment surpassed US$ 5,300 Mn in 2017, with consumables leading the growth, according to the findings of a recently published study by Fact.MR.

Rising incidences of cancer and associated mortalities are driving the need for efficient tissue diagnosis. Moreover, growing inclination toward less-invasive diagnostic procedures for cancer and other malignancies drove growth of histopathology testing equipment.

Request a report sample to gain comprehensive insights at https://www.factmr.com/connectus/sample?flag=S&rep_id=2240

“The American Cancer Society and National Center for Health Statistics have revealed that cancer cases in Unite States crossed 1,685,000 in 2017 and are likely to increase in the coming years. Likewise, according to WHO (World Health Organization) report, emerging economies such as India are witnessing an increase in cancer mortality rates with India reflecting 79 per 100,000 deaths. This has pushed the demand for efficient diagnosis of the disease, which is expected to translate into an increase in histopathology testing equipment sales crossing US$ 5,500 Mn by end of 2018”. –Lead Analyst, Fact.MR Medical Diagnostics Division

histopathology testing equipment market 1

Consumables are likely to account for nearly 80% revenue share of the market, according to the report. Demand for instruments in the histopathology testing equipment market is projected to expand at a relatively slow pace compared to consumables, making them a lucrative area for manufacturers from an investment standpoint.

Reagents and Antibodies to Spearhead Growth of Histopathology Testing Equipment Market

Sales of consumables in the histopathology testing equipment market are estimated to be on an upswing in 2018, says the report. The growth in sales of consumables is largely attributed to the increasing demand for reagents and antibodies. Increasing use of reagents and kits in genomics, sequencing and diagnosis of chronic diseases remains instrumental in driving their sales worldwide. Fact.MR envisages that demand for reagents and antibodies is projected to expand at a significant rate of over 5.5 % in the coming years.

The growth of histopathology testing equipment market is also influenced by macroeconomic aspects such as rising geriatric population. Increasing geriatric population is closely associated with chronic disorders and diseases, which is expected to push the demand for histopathology testing equipment worldwide.

Request More Information about Report Methodology
https://www.factmr.com/connectus/sample?flag=RM&rep_id=2240

On this front, the report reveals that the demand for histopathology testing equipment across emerging economies in Asia Pacific such as China and India is projected to expand at a higher rate. According to United Nations, the number of aging population in India is expected to rise by 64 percent doing the 2015-2030 timeline, whereas China is likely to reflect a 71 percent increase in same time frame. This aspect continues to influence the use of histopathology testing equipment in a bid to reduce mortalities and facilitate health to the aged.

The demand for histopathology testing equipment for disease diagnosis applications is projected to expand at a stellar pace in the future. 2017 witnessed a positive spike in sales of histopathology testing equipment for disease diagnosis and the status quo is likely to continue in 2018 and ahead. Use of histopathology testing equipment in drug discovery is another field triggering the sales of histopathology testing equipment, in turn supporting growth of the overall histopathology testing equipment market, according to the report.

Histopathology testing equipment sales are largely concentrated among diagnostic centers, followed by hospital based laboratories. Sales of histopathology testing equipment among diagnostic centers maintained a 1.4x lead over those in hospitals and the trend is expected to continue in the long run, according to Fact.MR.

Get More Insights- https://www.prnewswire.com/news-releases/consumables-spearhead-gains-in-histopathology-testing-equipment-market-as-sales-likely-to-reach-us-5-5-billion-in-2018-says-fact-mr-888579674.html

The outlook of the histopathology testing equipment market is likely to remain positive in the future, with the market proceeding at a value CAGR of 4.8% throughout the 2018-2028 timeline.

Explore Fact.MR’s Coverage on the Healthcare Domain

Radiation proctitis treatment market: A recent study by Fact.MR on the radiation proctitis treatment market offers a 10-year forecast analysis for the period 2018 to 2028. The study analyzes key trends that are currently determining the growth of the market. This report covers key dynamics, including drivers, restraints, and opportunities for leading market players along with key stakeholders and emerging players.

Radiation Nephropathy Treatment and Management Market: Fact. MR’s extensive coverage on the radiation nephropathy treatment and management market offers in-depth insights about the prominent growth dynamics that are likely to aid expansion of growth prospects in the near future. Data has been presented in the form of key segments across prominent geographies, along with important information concerning key manufacturers operating within the industry.

Cancer therapeutics market: The global cancer therapeutics market study published by Fact.MR offers an unbiased analysis of the prominent drivers, opportunities and trends expected to shape future expansion outlook. The report provides a comprehensive assessment on the prominent segments and geographies which are likely to benefit market players in forthcoming years.

About Fact.MR

Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. We have offices in US and Dublin, whereas our global headquarter is in Dubai. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Reach out to us with your goals, and we’ll be an able research partner.

Contact:
US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583
E: sales@factmr.com
Research Insight: https://www.factmr.com/report/2240/histopathology-testing-equipment-market
Press Release: https://www.factmr.com/media-release/723/histopathology-testing-equipment-market
Follow Us: LinkedIn | Twitter

Categories
Pharmaceutical

Burgeoning Demand for Single-Lumen Microcatheters In Healthcare Facilities to Uphold Market Growth: Report Fact.MR

As per Fact.MR – a market research and competitive intelligence provider, the global sales of coronary microcatheters was valued at around US$ 179 Mn in 2020, and is predicted to expand at a CAGR of 6.7% over the forecast period (2021–2031).

Factors boosting demand for coronary microcatheters include rapid adoption of innovative technologies in the healthcare sector and increasing prevalence of cardiovascular diseases across the world. Moreover, increasing number of players in the market is going to make this space highly competitive and also opportunistic. Diseases such as myocardial infarction and number of patients undergoing cardiology procedures such as angioplasty are increasing demand for coronary microcatheters.

To remain ‘ahead’ of your competitors, request a sample
https://www.factmr.com/connectus/sample?flag=S&rep_id=3971

 “Increasing adoption of steerable microcatheters is expected to drive market growth over the coming years,” says an analyst of Fact.MR.

coronary microcatheters market product by FactMR

Coronary Microcatheters Categorization as Per Industry Research

  • By Product

    • Single-lumen Coronary Microcatheters
    • Dual-lumen Coronary Microcatheters
    • Guide Extension Coronary Microcatheters

  • By Tip Type

    • Steerable Coronary Microcatheters
    • Angled Tip Coronary Microcatheters
    • Straight Tip Coronary Microcatheters

  • By Material

    • Stainless Steel Coronary Microcatheters
    • Stainless Steel+ Polytetrafluoroethylene – PTFE Coronary Microcatheters
    • Tungsten-braided Shaft Coronary Microcatheters
    • Platinum/Tungsten Coil Coronary Microcatheters
    • Others

  • End User

    • Coronary Microcatheters for Hospitals
    • Coronary Microcatheters for Ambulatory Surgical Centers
    • Coronary Microcatheters for Cardiac Catheterization Laboratories
    • Coronary Microcatheters for Specialty Clinics

For Comprehensive Insights Ask An Analyst Here
https://www.factmr.com/connectus/sample?flag=AE&rep_id=3971

Key Takeaways from Market Study

  • Single-lumen coronary microcatheters expected to contribute more than 52% revenue share in the market by 2031.
  • Demand for angled tip coronary microcatheters expected to increase at a CAGR of 7.6% due to their mandatory use in angled lesions or vessels.
  • Hospitals to dominate the market among all end-user segments and expected to reach US$ 287.8 Mn by 2031.
  • The U.S. holds a prominent share in the global market due to increasing number of coronary microcatheter manufacturing companies in the country. This market is expected to rise at a CAGR of 7.2% through 2031.

Get Customization on this Research Report for specific research solutions:
https://www.factmr.com/connectus/sample?flag=RC&rep_id=3971

Market Driver

Obesity has become a major risk factor for a variety of cardiovascular disorders around the globe. Obesity creates an inappropriate or excessive accumulation of fats inside the artery lumen, which can lead to a variety of health issues, including coronary heart disease. Thus, increasing rate of obesity will drive demand for coronary microcatheters across the world over the coming years.

Who is Winning?

The global coronary microcatheters market is set to grow due to rise in demand for minimally invasive procedures. Leading industry players are set to focus on research & development as well as strategic & geographic expansions in order to strengthen their presence across regions.

  • Boston Scientific Corporation
  • Teleflex Corporation
  • ASAHI INTECC USA, INC.
  • Medtronic
  • Terumo Corporation
  • KANEKA CORPORATION
  • CookMerit Medical Systems
  • Merit Medical Systems
  • Nipro Corporation
  • OrbusNeich Medical Company Limited
  • Baylis Medical Company, Inc
  • Interventional Medical
  • Device Solutions (IMDS)

For More Insights https://www.biospace.com/article/cardiac-ablation-technologies-market-growth-will-be-driven-by-high-reliance-of-electro-physiologists-on-new-ablation-devices-fact-mr/

Want more insights?

Fact.MR brings a comprehensive research report on forecasted revenue growth at the global, regional, and country levels, and provides an analysis of the latest industry trends in each of the sub-segments from 2016 to 2031.

The coronary microcatheters market is segmented in detail to cover every aspect of the market and present a complete market intelligence approach to the reader. The study provides compelling insights on the basis of product, tip type, material, and end user, and main regions.

About Fact.MR

Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. We have offices in the US and Dublin, whereas our global headquarter is in Dubai. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have in our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Reach out to us with your goals, and we’ll be an able research partner.

Contact:
US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583

Corporate Headquarter:
Unit No: AU-01-H Gold Tower (AU),
Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,
Dubai, United Arab Emirates
E: sales@factmr.com
Website: https://www.factmr.com

Categories
Pharmaceutical

Demand for ELISA Test for Poultry Diagnostics In Asia Pacific Is Anticipated to Surge at an Impressive CAGR of 11% : Fact.MR

The global sales of poultry diagnostics are projected to expand at a healthy CAGR of 9% till 2031, surpassing US$ 660 Mn in valuation, reports Fact.MR, a market research and competitive intelligence provider. Historical data suggests that the market expanded at a CAGR of 8.3% from 2016 to 2020.

The primary cause for significant growth in demand for poultry diagnostics is rising outbreaks of poultry diseases worldwide. These flock infections affect world trade in layers poultry, broilers, and turkeys. As a result, ongoing efforts are being made to increase awareness among farmers about these diseases. Different bacteria, fungi, viruses, protozoon pathogens, and environment and nutritional deficiencies are causing these diseases.

To remain ‘ahead’ of your competitors, request a sample
https://www.factmr.com/connectus/sample?flag=S&rep_id=6747

Rising prevalence of these infectious diseases and growing threat of antibiotic resistant microbes are key factors bolstering demand for poultry diagnostics across the world. Also, concerns of bacterial and viral transmission from birds to human consumers is supporting the use of diagnostics, as poultry consumption continues growing worldwide.

“Growing incidence of zoonotic diseases and rising awareness of consumers towards safety of poultry products to boost demand for poultry diagnostics over coming years,” says a Fact.MR analyst.

Key Segments Covered in Poultry Diagnostics Industry Research

  • By Test

    • ELISA Test (Enzyme-linked Immunoassays)
    • PCR Test (Polymerase Chain Reaction)

  • By Disease

    • Avian Salmonellosis
    • Avian Influenza
    • Newcastle Disease
    • Avian Mycoplasmosis
    • Avian Pasteurellosis
    • Infectious Bronchitis
    • Infectious Bursal Disease
    • Avian Encephalomyelitis
    • Avian Reovirus
    • Chicken Anaemia

  • By Service

    • Bacteriology
    • Virology
    • Parasitology

For Comprehensive Insights Ask An Analyst Here
https://www.factmr.com/connectus/sample?flag=AE&rep_id=6747

Key Takeaways from Market Study

  • By test, ELISA to generate 52% of total market revenue.
  • Market for poultry diagnostics to grow 1.8X in value by 2031.
  • U.S. to remain dominant in North American market expanding at 6% CAGR through 2031.
  • Market for poultry diagnostics in China to surge at CAGR of 12% over analysis period.
  • Within Europe, market in Germany to expand at a CAGR of 7% over next ten years.
  • Demand for PCR tests to rise at a CAGR of 8% over the decade.

Get Customization on this Research Report for specific research solutions:
https://www.factmr.com/connectus/sample?flag=RC&rep_id=6747

Key Players

  • IDEXX Laboratories
  • QIAGEN N.V.
  • Thermo Fisher Scientific
  • Zoetis
  • GD Animal Health
  • IDvet
  • AffiniTech LTD
  • AgroBioTek Internacional
  • BioNote
  • BioChek
  • Boehringer Ingelheim
  • MEGACOR Diagnostik GmbH
  • BioInGenTech Biotechnologies.

For More Insights 
https://www.biospace.com/article/increasing-application-in-oncology-and-cancer-treatment-propelling-human-umbilical-vein-endothelial-cells-huvec-market-growth-fact-mr/

More Valuable Insights

Fact.MR, in its new offering, presents an unbiased analysis of the poultry diagnostics market, presenting historical market data (2016-2020) and forecast statistics for the period of 2021-2031.

The study reveals essential insights on the basis of test (ELISA test and PCR test), disease (avian salmonellosis, avian influenza, Newcastle disease, avian mycoplasmosis, avian pasteurellosis, infectious bronchitis, infectious bursal disease, avian encephalomyelitis, avian reovirus, and chicken anaemia), and service (bacteriology, virology, and parasitology), across major regions of the world (North America, Europe, Asia Pacific, Central & South America, and the Middle East & Africa).

About Fact.MR

Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. We have offices in the US and Dublin, whereas our global headquarter is in Dubai. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have in our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Reach out to us with your goals, and we’ll be an able research partner.

Contact:
US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583

Corporate Headquarter:
Unit No: AU-01-H Gold Tower (AU),
Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,
Dubai, United Arab Emirates
E: sales@factmr.com
Website: https://www.factmr.com

Categories
Pharmaceutical

Demand of Respiratory Syncytial Virus (RSV) Molecular Diagnostics Is Predicted to Grow at a Staggering CAGR of 9% By 2031

Fact.MR, a market research and competitive intelligence provider, projects the global demand for respiratory syncytial virus (RSV) diagnostics to progress positively, surging at a CAGR of above 9% across the 2021-2031 forecast period.

Growing demand for point of care testing of respiratory syncytial virus (RSV)-infected patients and developments in the field of specific markers such as proteomics and genomic are set to accelerate market growth over the coming years.

Increase in the number of patients suffering from RSV infections has raised the overall burden of the disease, and, as such, has fuelled demand for RSV diagnostics globally. Approval of respiratory syncytial virus diagnostic assays & kits is further opening up various opportunities for market players.

To remain ‘ahead’ of your competitors, request a sample
https://www.factmr.com/connectus/sample?flag=S&rep_id=6736

North America dominates the market for respiratory syncytial virus diagnostics due to advanced technologies and innovation across the region, while the market in Asia Pacific is expected to surge at a high growth rate over the forecast period due to increasing burden of RSV infections among the population.

“Growing incidence of respiratory syncytial virus infections globally to boost demand for RSV diagnostics over coming years,” says a Fact.MR analyst.

respiratory syncytial virusrsv diagnostics market by FactMR

Key Market Segments Covered in Respiratory Syncytial Virus Diagnostics Industry Research

  • By Technology

    • RSV Molecular Diagnostics
    • RSV Monoclonal Antibodies
    • Immunoassays
    • Differential Light Scattering
    • Artificial Intelligence
    • Liposomes
    • Flow Cytometry
    • Chromatography
    • Diagnostic Imaging
    • Gel Microdroplets

  • By End Users

    • Respiratory Syncytial Virus Diagnostics at Hospitals
    • Respiratory Syncytial Virus Diagnostics at Nursing Homes
    • Respiratory Syncytial Virus Diagnostics at Commercial Laboratories
    • Respiratory Syncytial Virus Diagnostics at Public Health Laboratories

For Comprehensive Insights Ask An Analyst Here
https://www.factmr.com/connectus/sample?flag=AE&rep_id=6736

Key Takeaways from Market Study

  • Market for respiratory syncytial virus diagnostics to grow 2.3X in value by 2031, and reach a valuation of US$ 1.3 Bn by 2031.
  • RSV diagnostic kits & assays account for more one-third of the global market share.
  • Market for RSV diagnostics in China to top US$ 253 Mn by 2031.
  • Demand for respiratory syncytial virus diagnostics in Canada to increase at CAGR of 7.4%.
  • Market in Japan anticipated to expand at CAGR of 6% from 2021 to 2031.
  • New technological advancements in the field of diagnostics to boost market growth over next 10 years.

Get Customization on this Research Report for specific research solutions:
https://www.factmr.com/connectus/sample?flag=RC&rep_id=6736

Winning Strategy of Key Market Players

Various companies are focusing on organic growth strategies such as product launches, product approvals, and patents. Inorganic growth activities witnessed in the market are acquisitions and partnership & collaborations.

  • Abbott Laboratories
  • Becton
  • Dickinson and Company
  • BioMérieux SA
  • Bio-Rad Laboratories
  • Coris BioConcept
  • DiaSorin Molecular LLC (DiaSorin Inc)
  • F. Hoffmann-La Roche AG
  • Merck KgaA
  • Quest Diagnostics Incorporated
  • Quidel Corporation
  • Thermo Fisher Scientific

For More Insights https://www.biospace.com/article/rising-cases-of-microbial-diseases-add-to-already-high-demand-for-antimicrobial-susceptibility-tests-fact-mr-study/

More Valuable Insights

Fact.MR, in its new offering, presents an unbiased analysis of the respiratory syncytial virus diagnostics market, presenting historical market data (2016-2020) and forecast statistics for the period of 2021-2031.

The study reveals essential insights on the basis of technology (molecular diagnostics, monoclonal antibodies, immunoassay, differential light scattering, artificial intelligence, liposomes, flow cytometry, chromatography, diagnostic imaging, and gel microdroplets) and end user (hospitals, nursing homes, commercial laboratories, and public health laboratories), across major regions of the world (North America, Europe, Asia Pacific, Central & South America, and the Middle East & Africa).

About Fact.MR

Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. We have offices in the US and Dublin, whereas our global headquarter is in Dubai. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have in our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Reach out to us with your goals, and we’ll be an able research partner.

Contact:
US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583

Corporate Headquarter:
Unit No: AU-01-H Gold Tower (AU),
Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,
Dubai, United Arab Emirates
E: sales@factmr.com
Website: https://www.factmr.com

Categories
Pharmaceutical

Why are Biopsy Instruments Reprocessing Extensively used in Cardiovascular Surgeries: Latest Fact.MR’s Study

According to a latest report by Fact.MR, a market research and competitive intelligence provider, on medical device reprocessing, the global market is anticipated to top US$ 3 Bn by 2031, surging at a CAGR of 16% over the coming ten years.

Adoption of low-priced reprocessed medical devices is increasing at a rapid pace as compared to brand new devices. Also, elevated efforts for reducing regulated medical waste (RMW) are supporting growth of the market for medical device reprocessing. Furthermore, rising number of surgical procedures associated with growing prevalence of chronic diseases is expected to further nudge market growth in future.

To remain ‘ahead’ of your competitors, request a sample
https://www.factmr.com/connectus/sample?flag=S&rep_id=6721

Medical device reprocessing practices are regulated by various regional regulatory authorities. Changing regulatory scenario favouring medical device reprocessing in several countries such as France and Japan will open up new areas of opportunity for market players.

“Rising efforts towards reducing regulated medical waste to propel demand for medical device reprocessing over coming years,” says a Fact.MR analyst.

medical device reprocessing marketby FactMR

Key Segments Covered in Medical Device Reprocessing Industry Research

  • By Product & Service

    • Reprocessing Support & Services
    • Reprocessing Medical Devices

  • By Device

    • Catheters
    • Laparoscopy Instruments
    • Biopsy Instruments
    • Endoscopy Instruments
    • Cables, Columns, Curves and Cutters

  • By Application

    • Medical Device Reprocessing for Cardiology
    • Medical Device Reprocessing for Gastroenterology, Urology, and Gynaecology
    • Medical Device Reprocessing for Arthroscopy and Orthopaedic Surgery
    • Medical Device Reprocessing for General Surgery and Anaesthesia

For Comprehensive Insights Ask An Analyst Here
https://www.factmr.com/connectus/sample?flag=AE&rep_id=6721

Key Takeaways from Market Study

  • Market for medical device reprocessing to grow 2.2X in value by 2031.
  • Demand for medical device reprocessing support and services to surge at a CAGR of 15% across the forecast period.
  • North America holds 42% revenue share in the global market.
  • Patient preference towards low-cost reprocessed medical devices is the main factor driving this market.
  • Market for medical device reprocessing in China to expand at a CAGR of 15.2% across the assessment period.
  • Demand for cardiovascular reprocessed devices to remain high over next 10 years.
  • Stryker Corporation and Johnson & Johnson are the top two companies providing medical device reprocessing services.

Get Customization on this Research Report for specific research solutions:
https://www.factmr.com/connectus/sample?flag=RC&rep_id=6721

Winning Strategy of Key Market Players

Top companies operating in the industry are focussed on increasing the safety standards of reprocessed medical devices by adding steps such as sterilization and microbial load testing of the devices.  Key companies are investing in research & development activities to further enhance product quality. Many players are also focussing on developing new techniques of remanufacturing and repackaging medical devices.

  • Stryker Corporation
  • Johnson & Johnson
  • Vanguard AG
  • Medline ReNewal
  • Medtronic plc
  • SteriPro
  • Pioneer Medical Devices AG
  • Vascular Solutions
  • HYGIA Health Services
  • ReNu Medical
  • SureTek Medical
  • Centurion Medical Products Corporation.

For More Insights
https://www.biospace.com/article/incorporation-of-natural-ingredients-to-propel-sales-of-anti-ageing-and-anti-wrinkle-products-fact-mr-concludes-in-latest-market-analysis/

More Valuable Insights

Fact.MR, in its new offering, presents an unbiased analysis of the medical device reprocessing market, presenting historical market data (2016-2020) and forecast statistics for the period of 2021-2031.

The study reveals essential insights on the basis of product & service (reprocessing support & services and reprocessing medical devices) device (catheters, laparoscopy instruments, biopsy instruments, endoscopy instruments, cables, and columns, curves & cutters), and application (cardiology, gastroenterology, urology , gynaecology, arthroscopy, orthopaedic surgery, general surgery, and anaesthesia), across major regions of the world (North America, Europe, Asia Pacific, Central & South America, and the Middle East & Africa).

About Fact.MR

Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. We have offices in the US and Dublin, whereas our global headquarter is in Dubai. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have in our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Reach out to us with your goals, and we’ll be an able research partner.

Contact:
US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583

Corporate Headquarter:
Unit No: AU-01-H Gold Tower (AU),
Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,
Dubai, United Arab Emirates
E: sales@factmr.com
Website: https://www.factmr.com

Categories
Pharmaceutical

Demand for Surgical Medical Lasers Is Poised to Surge at a CAGR of around 8.5% by 2031

As per a new report published by Fact.MR – a market research and competitive intelligence provider, the market for medical laser systems is poised to surge at a CAGR of around 8.5% and top US$ 7.5 Bn valuation by 2031.

Medical laser systems consist of a wide variety of monochromatic lights with a specific wavelength that have strong emissions and are highly concentrated. The characteristics of laser lights are defined by their power, wavelength, and pulsed or continuous wave operation. Laser lights are best known for laser tissue interaction: photothermal reactions, photochemical reactions, and photoablation.

To remain ‘ahead’ of your competitors, request a sample
https://www.factmr.com/connectus/sample?flag=S&rep_id=6711

“With advancements in laser technology, strides taken by photonics in the past decade, growing number of research activities, and collaborations between medical and research institutes have propelled the demand for medical laser systems,” says a Fact.MR analyst.      

Medical lasers are medical devices that use precisely focused light sources to treat or remove tissues, and are used in medical diagnosis and treatments such as photodynamic therapy, laser-assisted procedures, photomedicine, and light therapy. Medical lasers are used in a broad range of applications such as dermatology, ophthalmology, gynaecology, dentistry, and many more.

Medical lasers can be used for very precise surgical procedures due to their specific wavelength, which is focused in a narrow beam and creates a very high-intensity light. Rising demand for advanced laser-based treatments for eye disorders and increasing use of medical laser treatments for chronic diseases are major factors contributing to growth of the global medical laser systems market.

For Comprehensive Insights Ask An Analyst Here
https://www.factmr.com/connectus/sample?flag=AE&rep_id=6711

medical laser systems market by FactMR

Key Segments in Medical Laser Systems Industry Research

  • Product

    • Diode Medical Laser Systems
    • Dye Medical Laser Systems
    • Gas Medical Laser Systems
    • Solid State Medical Laser Systems

  • Application

    • Aesthetic Medical Lasers
    • Ophthalmic Medical Lasers
    • Surgical Medical Lasers
    • Dental Medical Lasers
    • Diagnostic Medical Lasers

Get Customization on this Research Report for specific research solutions:
https://www.factmr.com/connectus/sample?flag=RC&rep_id=6711

Key Takeaways from Market Study

  • Global medical laser systems market to top US$ 7.5 Bn by 2031.
  • Aesthetic lasers projected to reach around US$ 3.5 Bn by 2031.
  • Ophthalmic lasers projected to record around 5% CAGR over the next 10 years.
  • Market in Japan to record 4% CAGR over the forecast period of 2021- 2031.
  • China forecast to reach a projected market size above US$ 2 Bn by 2031.
  • Market in Canada projected to expand at above 6% CAGR over the next 10 years.

Market Competition

Top companies are adopting several organic and inorganic strategies to strengthen their position in the market. Most are focusing on expanding their production facilities and acquiring other businesses.

A great deal of investments is being made towards R&D projects aiming at developing innovative and advanced medical laser systems. This will further create growth opportunities for market players over the coming years.

  • In 2018, Alcon Inc. launched software and hardware enhancements to the WaveLight Refractive Suite. These new software updates enhance the graphical user interface of the Suite’s WaveNet Planning Station, EX500 Excimer Laser, and the FS200 Femtosecond Laser.

Key Companies Profiled

  • Biolase Inc.
  • Bausch & Lomb Holdings
  • Cardiogenesis Corporation, Inc.
  • Lumenis Ltd.
  • IRIDEX Corp.
  • Novadaq Technologies, Inc.
  • Photomedex, Inc.
  • Spectranetics Corporation
  • Syneron-Candela
  • Alcon Laboratories, Inc.

For More Insights https://www.biospace.com/article/canine-separation-anxiety-treatment-market-will-surpass-us-26-13-mn-by-2031-driven-by-surging-pet-adoption-fact-mr/

More Insights Available

Fact.MR, in its new offering, presents an unbiased analysis of the medical laser systems market, presenting historical demand data (2016-2020) and forecast statistics for the period of 2021-2031.

The study divulges essential insights on the market on the basis of product (diode laser systems, dye laser systems, gas laser systems, and solid state laser systems) and application (aesthetic lasers, ophthalmic lasers, surgical lasers, dental lasers, and diagnostics lasers), across seven major regions of the world (North America, Latin America, Europe, East Asia, South Asia, Oceania, and the Middle East & Africa).

About Fact.MR

Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. We have offices in the US and Dublin, whereas our global headquarter is in Dubai. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have in our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Reach out to us with your goals, and we’ll be an able research partner.

Contact:
US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583

Corporate Headquarter:
Unit No: AU-01-H Gold Tower (AU),
Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,
Dubai, United Arab Emirates
E: sales@factmr.com
Website: https://www.factmr.com

Categories
Pharmaceutical

Tissue Expanders Market to register a CAGR of 6.9% by the end of 2026

Growing prevalence of breast cancer is projected to rev up demand for tissue expanders globally. Moreover, increasing demand for reconstruction of face, neck and forehead due to injuries is projected to impact the global market growth of tissue expanders positively. Fact.MR states that the global market of tissue expanders is projected to reflect a CAGR of 6.9% over the forecast period, 2017-2026.

Request a report sample to gain comprehensive insights at https://www.factmr.com/connectus/sample?flag=S&rep_id=340

Factors Fuelling Growth of the Global Market

Growth of the global global tissue expanders market is mainly bound to various macro-economic and micro-economic factors. Increasing number of breast removal attributed to breast cancer surgeries is projected to rev up demand for tissue expanders globally. World Cancer Research Fund states that breast cancer accounts for nearly 25% of the new cases of cancer and is a common type of cancer globally. Growing need to improve the aesthetic beauty is further expected to contribute towards the global market growth of tissue expanders. Breast tissue expanders continue to remain increasingly preferred and highly popular clinical option among the customers.

According to the Aesthetic Society for Aesthetic Plastic Surgery, breast lift procedures and breast augmentation accounts for 56% of the overall cosmetic expenditures performed in 2016. Increasing number of surgeries has led to increasing demand for the reconstruction of scalp and forehead skin globally. These factors are expected to contribute towards the global market growth of tissue expanders during the forecast period.

tissue expanders market

Increasing number of road accidents lead to various injuries and scars on arms, head, legs and chest. Surge in the number of scars due to increasing number of road accidents is further expected to rev up demand for surgical interventions. According to the World Health Organization, more than 1.25 million people die in road accidents each year. These accidents have significantly led to legs, head, arms and chest injuries globally. Increasing number of road accidents is projected to remain a major factor that has revved up demand for treatment of the accident injuries and scars.

However, breakage or leakage of the silicon expanders is becoming a major concern for the tissue expansion treatment. Growing requirement of replacing the tissue expanders attributed to increasing leakage and spread of saline in the human body continues to increase demand for tissue expanders globally. Such incidences are expected to inhibit the global market growth of tissue expanders during the forecast period.

Request More Information about Report Methodology
https://www.factmr.com/connectus/sample?flag=RM&rep_id=340

Sales through Breast Reconstruction Application to Remain High

As need for reconstructing and uplifting breast arises, demand for anatomical tissue expanders is projected to increase globally. In terms of revenue, the anatomical tissue expanders product type segment is projected to witness robust growth in terms of revenue, recording for more than US$ 100 Mn by 2026-end. Further, the anatomical tissue expanders product type segment is projected to reflect significant CAGR throughout the forecast period.

On the basis of end uses, the specialty clinics end user segment is projected to witness the fastest growth during the forecast period. By 2017-end, the hospital end user segment is projected to witness the highest growth in terms of revenue, representing less than US$ 100 Mn.

Get More Insights- https://www.globenewswire.com/en/news-release/2018/05/03/1495896/0/en/Tissue-Expanders-Market-Breast-Reconstruction-Application-to-Generate-Significant-Revenues.html

Based on application, the breast reconstruction segment is projected to represent a significant revenue growth, accounting for more than US$ 150 Mn by 2026-end. On the other hand, the forehead skin and scalp reconstruction application segment is projected to reflect the highest CAGR throughout the forecast period.

Market Players

Major players in the global market of tissue expanders are Sientra Inc., PMT Corporation, Johnson & Johnson, Allergan Plc, Groupe Sebbin, Polytech Health & Aesthetics, AirXpanders Inc., Koken Co. Ltd., Guangzhou Wanhe Plastic Materials and GC Aesthetics.

Explore Fact.MR’s Coverage on the Healthcare Domain

Radiation proctitis treatment market: A recent study by Fact.MR on the radiation proctitis treatment market offers a 10-year forecast analysis for the period 2018 to 2028. The study analyzes key trends that are currently determining the growth of the market. This report covers key dynamics, including drivers, restraints, and opportunities for leading market players along with key stakeholders and emerging players.

Radiation Nephropathy Treatment and Management Market: Fact. MR’s extensive coverage on the radiation nephropathy treatment and management market offers in-depth insights about the prominent growth dynamics that are likely to aid expansion of growth prospects in the near future. Data has been presented in the form of key segments across prominent geographies, along with important information concerning key manufacturers operating within the industry.

Cancer therapeutics market: The global cancer therapeutics market study published by Fact.MR offers an unbiased analysis of the prominent drivers, opportunities and trends expected to shape future expansion outlook. The report provides a comprehensive assessment on the prominent segments and geographies which are likely to benefit market players in forthcoming years.

About Fact.MR

Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. We have offices in US and Dublin, whereas our global headquarter is in Dubai. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Reach out to us with your goals, and we’ll be an able research partner.

Contact:
US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583
E: sales@factmr.com
Research Insight: https://www.factmr.com/report/340/tissue-expanders-market
Press Release: https://www.factmr.com/media-release/329/tissue-expanders-market
Follow Us: LinkedIn | Twitter

Categories
Pharmaceutical

Dental Restorative Supplies Market- Rising Dental Disorder Awareness and Growing Root Canal Treatment Fuelling Adoption

Demand for dental restorative supplies is likely to be on an upswing as several industry-specific and macroeconomic factors continue to influence the dental space. Technological advancements have not left any domain untouched with manufacturers of dental restorative supplies focusing on new innovations in their product lines, says Fact.MR report.

Manufacturers of dental restorative supplies are focusing on developing and using advanced material in a bid to enhance the customer satisfaction quotient, achieving sustenance in the competitive dental restorative supplies marketplace.

Request a report sample to gain comprehensive insights at https://www.factmr.com/connectus/sample?flag=S&rep_id=1588

Fact.MR envisages that the demand for dental restorative supplies is projected to expand at a steady CAGR of 4.1% in terms of value during the period of assessment, 2018-2028. Sales of dental restorative supplies during the said period are likely to surpass US$ 6,000 Mn by end of 2028, says the report.

Sales of dental restorative supplies are likely to remain influenced with increasing investments in the dental space. This aspect is further fuelled with growing edentulous population that prefers unanchored dentures and dental cosmetic procedures.

dental restorative supplies market 2

In addition, the rising oral disease burden globally is anticipated to impact the growth of the dental restorative supplies market. World Health Organization (WHO) revealed that oral disease treatments are the fourth most expensive resulting in high economic burden among low and middle class population.

Distributors of dental restorative supplies are playing a major role in enhancing the visibility of dental restorative supplies across regional markets, reveals Fact.MR report. They are focused on enhancing the customer-manufacturer relationship to obtain tangible benefits and are providing information on price adjustments and changing trends.

The report says that the dental restorative supplies are driven toward customers largely by distributors as most of the composite material manufacturers are small scale players.

Sales of dental restorative supplies are expected to remain concentrated in the developed counties of Europe region, particularly the EU-4. Fact.MR foresees that the demand for dental restorative supplies in Europe region is largely influenced with growing cases of dental diseases, which is expected to translate into sales crossing US$ 1,800 Mn in Europe by 2028 end.

The market for dental restorative supplies in Asia Pacific excluding Japan (APEJ) region is expected to be optimistic and manufacturers of dental restorative supplies can expect significant momentum in the emerging countries of China and India during the assessment period.

Request More Information about Report Methodology
https://www.factmr.com/connectus/sample?flag=RM&rep_id=1588

Closely following the suit, developed countries in North America, particularly the United States, are likely to showcase notable demand for dental restorative supplies on the back of increasing occurrences of root canal in the region.

Composite dental restorative supplies are estimated to witness significant demand and adoption during the period of forecast. Sales of composite dental restorative supplies are estimated to touch US$ 2,200 Mn owing to their high durability and availability in different shades suiting the aesthetic requirements of the customer.

However, their post-operative sensitivity is expected to confine their scope of application in some cases. On the contrary, impression material is gaining high traction owing to rising demand for indirect restoration procedures, says the report.

Get More insights- https://www.prnewswire.com/news-releases/europe-s-dominion-in-dental-restorative-supplies-sales-to-remain-incontestable-says-fact-mr-866836984.html

Demand for dental restorative supplies in dental clinics is projected to expand at a relatively robust rate throughout the period of assessment as compared to hospitals. Hospitals lack wards needed for dental restoration, which is limiting use of dental restorative supplies in the hospital sector.

Future prospects of the dental restorative supplies market are expected to be bullish on account of changing customer approach toward dental aesthetics and treatment of dental caries coupled with increasing number of dental procedures worldwide. Moreover, environmental concerns associated with use of mercury in dental restorative supplies has led to the development of ceramic material and glass ionomers that deliver higher customer satisfaction in turn facilitating momentum to the adoption of dental restorative supplies.

Explore Fact.MR’s Coverage on the Healthcare Domain

Radiation proctitis treatment market: A recent study by Fact.MR on the radiation proctitis treatment market offers a 10-year forecast analysis for the period 2018 to 2028. The study analyzes key trends that are currently determining the growth of the market. This report covers key dynamics, including drivers, restraints, and opportunities for leading market players along with key stakeholders and emerging players.

Radiation Nephropathy Treatment and Management Market: Fact. MR’s extensive coverage on the radiation nephropathy treatment and management market offers in-depth insights about the prominent growth dynamics that are likely to aid expansion of growth prospects in the near future. Data has been presented in the form of key segments across prominent geographies, along with important information concerning key manufacturers operating within the industry.

Cancer therapeutics market: The global cancer therapeutics market study published by Fact.MR offers an unbiased analysis of the prominent drivers, opportunities and trends expected to shape future expansion outlook. The report provides a comprehensive assessment on the prominent segments and geographies which are likely to benefit market players in forthcoming years.

About Fact.MR

Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. We have offices in US and Dublin, whereas our global headquarter is in Dubai. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Reach out to us with your goals, and we’ll be an able research partner.

Contact:
US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583
E: sales@factmr.com
Research Insight: https://www.factmr.com/report/1588/dental-restorative-supplies-market
Press Release: https://www.factmr.com/media-release/556/dental-restorative-supplies-market
Follow Us: LinkedIn | Twitter

Categories
Pharmaceutical

Plasmapheresis Market to reach a valuation of over US$ 1.5 Bn by the end of 2026, Finds Fact.MR

The global demand of plasmapheresis market is likely to grow at a steady CAGR of over 7% during the forecast period 2017-2026, and reach a valuation of over US$ 1.5 Bn by the end of 2026. The market is likely to be impacted by a range of macro-economic and micro-economic factors.

Increasing emphasis on upgrading healthcare infrastructure, combined with higher awareness on treating thrombotic thrombocytopenic purpura (TTP) and autoimmune diseases are the key factors that will lead to increasing adoption of plasmapheresis as a first line of treatment.

Request a report sample to gain comprehensive insights at
https://www.factmr.com/connectus/sample?flag=S&rep_id=351

According to U.S. National Library of Medicine, the prevalence rate of TTP is in the range of 1.7 to 11 cases per million population in the U.S. In addition to TTP, increase in prevalence of autoimmune diseases and advancement in plasmapheresis is likely to drive the growth of the market during the assessment period in the U.S.

The market in Europe is likely to mimic the U.S. in terms of key driving factors, whereas greater emphasis on boosting healthcare infrastructure is likely to fuel market growth in Asia Pacific excluding Japan (APEJ) and Latin America. In terms of revenues, North America will continue to be a leading market, with U.S. accounting for the bulk of revenues.

The U.S. is home to some of the leading companies in the plasmapheresis market, and there is a high emphasis on research and development among universities and institutes. Collaboration between companies and institutions has also contributed to the growth of the market in the region.

global plasmapheresis market

To give readers detailed insights, the report offers segment-wise analysis on the global plasmapheresis market. The report has been segmented on the basis of product into instruments and disposables.

Currently, instruments account for a higher revenue share of the market, and is poised to grow at a CAGR of 5.7% during the forecast period. However, disposables segment is likely to grow at a higher CAGR, owing to which the revenue share of instruments will witness a decline of nearly 7% during the forecast period.

Request More Information about Report Methodology
https://www.factmr.com/connectus/sample?flag=RM&rep_id=351

On the basis of end-users, the report has segmented the market on the basis of biopharmaceutical companies, hospitals & clinics, and ‘other end-users’. According to the report, biopharmaceutical companies will account for the leading revenue share of the market.

There has been steady demand for plasmapheresis instruments and disposables from the biopharmaceutical industry. Exponential growth of the biotechnology industry is also a macro factor that is pushing the demand for plasmapheresis instruments and disposables.

The key end-use applications of plasmapheresis market include therapeutic and source plasma collection. The source plasma collection segment is likely to grow at a CAGR of 7.6% and surpass US$ 1 Bn in revenues by the end of the forecast period.

Get More Insights- https://www.globenewswire.com/en/news-release/2018/04/27/1488872/0/en/Global-Plasmapheresis-Market-Likely-to-Grow-at-Over-7-CAGR-through-2026.html

By technology, the key segments of the market include membrane filtration and centrifugation. The membrane filtration segment is likely to grow at a CAGR of 5.5% through 2026, reaching a value of nearly US$ 477 Mn. Some of the leading companies profiled in the report include Haemonetics Corporation, Asahi Kasei Kuraray Medical Co, Ltd., Terumo Corporation, B. Braun Melsungen AG, Baxter International Inc, Baxter International Inc, Kawasumi Laboratories, Inc, and Kaneka Corporation.

Explore Fact.MR’s Coverage on the Healthcare Domain

Radiation proctitis treatment market: A recent study by Fact.MR on the radiation proctitis treatment market offers a 10-year forecast analysis for the period 2018 to 2028. The study analyzes key trends that are currently determining the growth of the market. This report covers key dynamics, including drivers, restraints, and opportunities for leading market players along with key stakeholders and emerging players.

Radiation Nephropathy Treatment and Management Market: Fact. MR’s extensive coverage on the radiation nephropathy treatment and management market offers in-depth insights about the prominent growth dynamics that are likely to aid expansion of growth prospects in the near future. Data has been presented in the form of key segments across prominent geographies, along with important information concerning key manufacturers operating within the industry.

Cancer therapeutics market: The global cancer therapeutics market study published by Fact.MR offers an unbiased analysis of the prominent drivers, opportunities and trends expected to shape future expansion outlook. The report provides a comprehensive assessment on the prominent segments and geographies which are likely to benefit market players in forthcoming years.

About Fact.MR

Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. We have offices in US and Dublin, whereas our global headquarter is in Dubai. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Reach out to us with your goals, and we’ll be an able research partner.

Contact:
US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583
E: sales@factmr.com
Research Insight: https://www.factmr.com/report/351/plasmapheresis-market
Press Release: https://www.factmr.com/media-release/340/plasmapheresis-market
Follow Us: LinkedIn | Twitter

Categories
Pharmaceutical

Demand for Helicobacter Pylori Hospital Acquired Testing Kits Is Expected to Exhibit a CAGR of Around 15% over the Forecast Period (2021-2031)

As per Fact.MR – a market research and competitive intelligence provider, the Revenue Share of Americas hospital acquired infection testing was valued at US$ 595 Mn in 2020, and is expected to exhibit a CAGR of around 15% over the forecast period (2021-2031).

Increasing medical tourism is expected to aid the growth of emergency medicine services, including the use of ambulances, ambulatory surgical centers, and hospitals, which, in turn, will create demand for hospital acquired infection testing kits. Infants, elderly people, and people with weak immunity systems are at a greater risk of developing hospital acquired infections (HAIs). Many common antibiotics are resistant to various organisms present in hospitals. Widespread use of antibiotics in hospitals promotes the development of resistant bacteria. Urinary tract infection (UTI), surgical site infections, pneumonia, lung infections, and bacterial infections are commonly acquired hospital infections.

For More Insights Into The Market, Request a Sample of this Report –
https://www.factmr.com/connectus/sample?flag=S&rep_id=6592

“Surge in surgical procedures and government initiatives to control & create awareness regarding hospital acquired infections are anticipated to drive market growth over the coming years,” says a Fact.MR analyst.

As per the Centers of Disease Control and Prevention (CDC) estimates, in hospitals across the Americas alone, 1.7 million patients suffer from HAIs and 99,000 deaths occur every. This high mortality rate associated economic burden has compelled healthcare providers to device an effective strategy to lower infection rates.

The current COVID-19 pandemic crisis is expected to have a moderately positive impact on market growth. This can be attributed to growing number hospitalizations due to COVID-19 across the Americas. Prolonged hospital stays and frequent use of ventilators increase the chances of patients acquiring infections. Thus, as the number of hospitalizations is high, demand for HAI testing kits is expected to see a rise.

Segments as per Americas Hospital Acquired Infection Testing Industry Research

  • By Test
    • MSRA Testing Kits
      • MRSA Real-Time PCR Detection Kits
      • MRSA Rapid Test Kits
    • Staphylococcus aureus Detection Kits
      • Staphylococcus aureus Latex Test Kits
      • Staphylococcus aureus Assay Test Kits
    • Clostridium difficile Testing Kits
      • Clostridium difficile Detection Panels
      • Clostridium difficile Immunoassay Kits
    • Helicobacter pylori Testing Kits
      • Helicobacter pylori Rapid Antigen Test Kits
      • Helicobacter pylori IgG antibodies Test Kits
    • Rotavirus/ Adenovirus Real-time PCR Kits
      • RSV RT-PCR Test Kit
      • RSV Ag Rapid Test Kits
    • Strep A Rapid Testing Kits
    • Strep B Rapid Testing Kits
    • Mononucleosis Testing Kits
    • Calprotectin Test Kits
  • Modality
    • Immunoassay Testing
    • Point-of-care Testing
  • By Sample
    • Blood
    • Nasal Swabs
    • Urine
    • Stool
  • By End User
    • Hospitals
    • Diagnostic Laboratories
    • Cancer Research Institutes
    • Specialty Clinics
    • Home Care Settings

Share Your Requirements & Get Customized Reports –
https://www.factmr.com/connectus/sample?flag=RC&rep_id=6592

americas hospital acquired infection testing market modality by FactMR

Key Takeaways from Market Study

  • By test, helicobacter pylori testing kits hold around 26.4% value share of the total Americas market.
  • Based on modality, point-of-care testing is leading with 69% market share.
  • By end user, diagnostic laboratories dominate the HAI testing market with a value share of 35%, while on the other hand, home care settings are expected to increase at a higher CAGR of 23%.
  • By country, the U.S. dominates the Americas hospital acquired infection testing market with a value share of 58%.

Who is winning?

The Americas market is set to expand due to rise in incidence of hospital acquired infections. Leading industry players are set to focus on research & development as well as strategic & geographic expansion in order to strengthen their presence in the region.

  • Thermo Fisher Scientific
  • bioMérieux SA
  • Becton Dickinson & Co.
  • Abbott
  • Danaher
  • Quidel Corporation
  • BioFire Diagnostics
  • Qiagen

Get Full Access of Americas Hospital Acquired Infection Testing Market Exclusive Report
https://www.factmr.com/checkout/6592

Want more insights?

Fact.MR brings a comprehensive research report on forecasted revenue growth at the Americas, regional, and country levels, and provides an analysis of the latest industry trends in each of the sub-segments from 2016 to 2031.

The Americas hospital acquired infection testing market is segmented in detail to cover every aspect of the market and present a complete market intelligence approach to the reader. The study provides compelling insights on the basis of test, modality, sample, and end user, across three main regions.

Key Questions Answered in Report

  • Which geographic regions will continue to remain most profitable markets for hospital acquired infection testing?
  • Which parameters will bring a change in the demand for hospital acquired infection testing during the forecast period?
  • How will changing trends impact the market?
  • How will the COVID-19 pandemic impact market growth?
  • How can market players capture the low-hanging opportunities in developed regions?
  • What are the winning strategies of stakeholders in the hospital acquired infection testing market to upscale their position in this landscape?
  • What are the restraints that investors need to be aware of and might tackle while investing in the market?

For More Insights https://www.biospace.com/article/tumor-lysis-syndrome-treatment-demand-fuelled-by-favorable-reimbursement-policies-says-fact-mr/

About Us:

Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Our sales offices in United States and Dublin, Ireland. Headquarter based in Dubai, UAE. Reach out to us with your goals, and we’ll be an able research partner.

Contact:

US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583

Corporate Headquarter:
Unit No: AU-01-H Gold Tower (AU),
Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,
Dubai, United Arab Emirates
Email: sales@factmr.com
Visit Our Website: https://www.factmr.com